$1.79
-0.08 (-4.28%)
Open$1.87
Previous Close$1.87
Day High$1.89
Day Low$1.76
52W High$36.00
52W Low$1.87
Volume—
Avg Volume92.7K
Market Cap13.45M
P/E Ratio—
EPS$-1.34
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,950.8% upside
Current
$1.79
$1.79
Target
$36.71
$36.71
$29.06
$36.71 avg
$43.55
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.85M | 1.83M | 1.75M |
| Net Income | 558.6K | 478.0K | 437.1K |
| Profit Margin | 30.2% | 26.2% | 25.0% |
| EBITDA | 671.1K | 736.1K | 607.5K |
| Free Cash Flow | 473.4K | 406.9K | 399.5K |
| Rev Growth | +1.8% | +20.8% | +4.5% |
| Debt/Equity | 0.11 | 0.11 | 0.14 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |